1,417
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Expression of Cyclin D1 gene in ovarian cancer and effect of silencing its expression on ovarian cancer cells based on the Oncomine database

, , , , , , & show all
Pages 9290-9300 | Received 15 Aug 2021, Accepted 26 Oct 2021, Published online: 22 Nov 2021

References

  • Song YB. [2018 National Cancer Statistics]. China Med News. 2018;33:6.
  • Gülseren V, Kocaer M, Güngördük Ö, et al. Isolated pulmonary metastases in patients with cervical cancer and the factors affecting survival after recurrence. Ginekol Pol. 2019;89(11):593–598.
  • Zhao L, Tang X, Luo R, et al. MicroRNA-490-5P targets CCND1 to suppress cellular proliferation in glioma cells and tissue through cell cycle arrest. Curr Neurovasc Res. 2018;15(3):246–255.
  • Han D, Wang J, Cheng G. LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis. Oncotarget. 2017;9(2):2395–2409.
  • Luo J, Yan R, He X, et al. SOX2 inhibits cell proliferation and metastasis, promotes apoptotic by downregulating CCND1 and PARP in gastric cancer. Am J Transl Res. 2018;10:639–647.
  • Yang Z, Lu W, Ning L, et al. Downregulation of long non-coding RNA MALAT1 induces tumor progression of human breast cancer through regulating CCND1 expression. Open Life Sci. 2016;11(1):232–236.
  • Guo QS, Huang X, Wu YZ, et al. RNA interference targeting EGFR on proliferation of human ovarian carcinoma cell line SKOV_3. Acta Acad Med Militaris Tertiae. 2009;23.
  • Fathi E, Farahzadi R, Valipour B, et al. Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation. PloS One. 2019;14(4):e0215678.
  • Zeinali S, Tuncel A, Yüzer A, et al. Imaging and Detection of Cell Apoptosis by In vitro Photodynamic Therapy Applications of Zinc (II) Phthalocyanine on Human Melanoma Cancer. Photodiagnosis Photodyn Ther. 2021;36:102518.
  • Wilkey JF, Buchberger G, Saucier K, et al. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium. Mol Carcinog. 2009;48:853–861.
  • Jing H, Friedman E. Depleting Mirk Kinase Increases Cisplatin Toxicity in Ovarian Cancer Cells. Genes Cancer. 2010;1(8):803–811.
  • Liang K, Meng Z, Ping HE. LRRC3B is Downregulated in Non-small Cell Lung Cancer and Connected with Cell Proliferation and Invasion. Chinese J Lung Cancer. 2016;19:177–183.
  • El-Arabey AA, Denizli M, Kanlikilicer P, et al. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal. 2020;68:109539.
  • Jiang X, Li W, Li X, et al. Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer. Cancer Manag Res. 2019;11:4371.
  • Ray-Coquard I, Pautier P, Pignata S, et al. Olaparib plus bevacizumab as first-line maintenance in ovarian cancer. N Engl J Med. 2019;381(25):2416–2428.
  • Mohammedi L, Doula FD, Mesli F, et al. Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters. Afr Health Sci. 2019;19(2):2140–2146.
  • Martín-Garcia D, Navarro A, Valdés-Mas R, et al. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma. Blood. 2019;133(9):940–951.
  • Xie M, Zhao F, Zou X, et al. The association between CCND1 G870A polymorphism and colorectal cancer risk: a meta-analysis. Medicine (Baltimore). 2017;96(42):e8269.
  • Hou G-X, Liu P, Yang J, et al. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan–Meier plotter. PloS One. 2017;12(3):e0174515.
  • Shan YS, Hsu HP, Lai MD, et al. Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer. Oncol Lett. 2017;14:4517–4526.
  • Chen J, Li X, Cheng Q, et al. Retracted: effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells. J Cell Biochem. 2018;119(2):2368–2380.
  • Yu L, Ye F, Li YY, et al. Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis. Carcinogenesis. 2020;41:678–688.